(Q54077161)

24 May 2018

title

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. (English)

1 reference

24 May 2018

0 references

0 references

11

Möller HJ

1 reference

24 May 2018

author name string

Padberg F

1

1 reference

24 May 2018

Feneberg W

2

1 reference

24 May 2018

Schmidt S

3

1 reference

24 May 2018

Schwarz MJ

4

1 reference

24 May 2018

Körschenhausen D

5

1 reference

24 May 2018

Greenberg BD

6

1 reference

24 May 2018

Nolde T

7

1 reference

24 May 2018

Müller N

8

1 reference

24 May 2018

Trapmann H

9

1 reference

24 May 2018

König N

10

1 reference

24 May 2018

Hampel H

12

1 reference

24 May 2018

publication date

1 October 1999

1 reference

24 May 2018

Journal of Neuroimmunology

published in

1 reference

24 May 2018

volume

99

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

218-223

1 reference

24 May 2018

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Interleukin-6 is elevated in plasma in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

IL-6 cytokine family and signal transduction: a model of the cytokine system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

IL-6 detection in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Pathology and pathogenesis of demyelinating diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900120-4

7 January 2021

10.1016/S0165-5728(99)00120-4

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018